During the past decade, National Hospital Organization Asahikawa Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Asahikawa Medical Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Japan Clinical Oncology Group" with 3 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Asahikawa Medical Center" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Asahikawa Medical Center" are "Non-Small Cell Lung Cancer" (3 trials), "Rheumatoid Arthritis" (3 trials), "Systemic Lupus Erythematosus" (3 trials), "Alzheimer´s Disease" (1 trials) and "Amyotrophic Lateral Sclerosis" (1 trials). Many other conditions were trialed in "National Hospital Organization Asahikawa Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Asahikawa Medical Center" are "Drug" (18 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (3 trials), "Carboplatin" (2 trials), "A: Radiotherapy alone" (1 trials) and "Active Comparator (erlotinib)" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Asahikawa Medical Center" are 21 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Asahikawa Medical Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in National Hospital Organization Asahikawa Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Asahikawa Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".